Astellas Pharma, Inc. (ALPMY)

13.29 -0.07 (-0.52%) USD  |  OTCM  |  Dec 31, 16:00
More

Astellas Pharma EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for ALPMY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Pfizer Inc. Upgrade
Takeda Pharmaceutical Co., Ltd. Upgrade
Nxera Pharma Co., Ltd. Upgrade
PeptiDream Inc. Upgrade
Stemcell Holdings, Inc. --